@article{25c031e037a34800b4595d86c270b2e8,
title = "Reply to Santhanam Sundar's letter to the Editor Re: Arnulf Stenzl, Nigel C. Cowan, Maria de Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18",
author = "Arnulf Stenzl and Cowan, {Nigel C.} and {De Santis}, Maria and Kuczyk, {Markus A.} and Merseburger, {Axel S.} and Ribal, {Maria Jos{\'e}} and Amir Sherif and Witjes, {J. Alfred} and Thierry Lebret",
note = "Funding Information: Dr. Stenzl is a company consultant for GE Healthcare and Novartis; has received speaker honoraria from Amgen and Novartis; has participated in trials for MEDAC, Photocure, Immatics, Novartis, Johnson & Johnson, Amgen, and Bayer; and has received research grants from Immatics. Dr. Witjes is a company consultant for Endo Pharm, Astellas, Spectrum Pharmaceuticals, Sanofi Pasteur, GE Healthcare, and Telormedix; has received speaker honoraria from GE Healthcare; and has participated in trials for MEL Amsterdam, Telormedix, and Photocure Oslo. Dr. Cowan has nothing to disclose. Dr. de Santis is a company consultant for Glaxo Smith Kline, Amgen, Bayer, Novartis, and Pierre-Fabre; has received speaker honoraria from Pfizer, Eli Lilly, Sanofi Aventis, Novartis, and Roche; has received fellowship and travel grants from Bayer, Novartis, Pfizer, Amgen, and Sanofi Aventis. Dr. Kuczyk has equity interests in Bayer Healtcare, Astellas, Storz, Pfizer, and Wyeth; is a company consultant for Bayer Healthcare, Pfizer, Astra Zeneca, Astellas, and Storz; has received speaker honoraria from Bayer, Pfizer, Medac, Astellas, Bayer Healthcare, and Astellas; has participated in trials for Astra Zeneca, Pfizer, Bayer Healthcare, Astellas, and Ipsen; and has received research grants from Wyeth. Dr. Merseburger is a company consultant for Ipsen Pharma and Bayer; has received speaker honoraria from Ipsen Pharma, Wyeth, Astellas, Novartis, Pfizer, and SEP; has participated in trials for Astra Zeneca, Bayer, Pfizer, TEVA, and Novartis; and has received research grants from Wyeth. Dr. Sherif has received speaker honoraria from Orion Pharma and MEDAC AB. Dr. Lebret is a company consultant for Ipsen, Amgen, Sanofi, and Novartis; has received speaker honoraria from Ferring; and has participated in trials for Astellas and Takeda. Copyright: Copyright 2013 Elsevier B.V., All rights reserved.",
year = "2012",
month = aug,
doi = "10.1016/j.eururo.2012.04.042",
language = "English",
volume = "62",
pages = "45--46",
journal = "European Urology",
issn = "0302-2838",
number = "2",
}
